Windtree Therapeutics Targets $520 Million in Funding to Secure BNB Reserve

robot
Abstract generation in progress

Windtree Therapeutics (WINT), a publicly listed biotechnology company, announced today that it has entered into two significant financial agreements to raise up to $520 million for the acquisition of BNB (BNB).

BNB2.46%
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)